Medicenna Therapeutics Corp.
MDNAF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807983
No open-market purchases or sales by Medicenna Therapeutics Corp. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Medicenna Therapeutics Corp. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −2 vs. Q3 2021
- Shares held
- 4.44M
- +1.40M (+45.9%) vs. Q3 2021
- Total value
- $7.42M
- −$1.25M (−14.4%) vs. Q3 2021
- New holders
- 2
- 8 more added
- Sold out
- 4
- 7 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDNAF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $200.4K |
| Q3 2024 | 1 | $175.0K |
| Q2 2024 | 1 | $145.0K |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $40.9K |
| Q3 2023 | 26 | $2.45M |
| Q2 2023 | 28 | $4.75M |
| Q1 2023 | 28 | $6.25M |
| Q4 2022 | 28 | $4.75M |
| Q3 2022 | 29 | $9.67M |
| Q2 2022 | 19 | $5.41M |
| Q1 2022 | 20 | $5.47M |
| Q4 2021 | 23 | $7.42M |
| Q3 2021 | 25 | $8.66M |
| Q2 2021 | 26 | $15.4M |
| Q1 2021 | 31 | $22.9M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Medicenna Therapeutics Corp.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 2,214,300 | $3.61M | 1.13% | +1,299,300+142.0% | Added |
| Verition Fund Management LLC | 539,051 | $879.0K | 0.01% | 00.0% | Unchanged |
| Worth Venture Partners, LLC | 513,089 | $837.0K | 0.42% | +298,059+138.6% | Added |
| Intact Investment Management Inc. | 359,800 | $752.0K | 0.02% | −25,800−6.7% | Reduced |
| ACT Capital Management, LLC | 152,500 | $249.0K | 0.18% | −197,500−56.4% | Reduced |
| Sigma Planning Corp | 140,050 | $228.0K | 0.01% | +109,550+359.2% | Added |
| Letko, Brosseau & Associates Inc | 100,000 | $163.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 99,000 | $161.0K | 0.00% | +87,100+731.9% | Added |
| Tocqueville Asset Management L.P. | 88,000 | $143.0K | 0.00% | −5,000−5.4% | Reduced |
| Vident Investment Advisory, LLC | 65,878 | $110.0K | 0.00% | +2,998+4.8% | Added |
| Rathbone Brothers plc | 40,000 | $66.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 27,633 | $45.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 21,676 | $35.0K | 0.00% | +2,000+10.2% | Added |
| Patriot Financial Group Insurance Agency, LLC | 17,900 | $29.0K | 0.00% | −5,000−21.8% | Reduced |
| Newman Dignan & Sheerar, Inc. | 13,915 | $23.0K | 0.01% | +1,000+7.7% | Added |
| McKinley Carter Wealth Services, Inc. | 12,594 | $21.0K | 0.00% | −19,643−60.9% | Reduced |
| Royal Bank of Canada | 10,853 | $18.0K | 0.00% | −37,436−77.5% | Reduced |
| K.J. Harrison & Partners Inc | 10,000 | $17.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 7,340 | $12.0K | 0.00% | −31,265−81.0% | Reduced |
| Tower Research Capital LLC (TRC) | 4,872 | $8.00K | 0.00% | +4,672+2,336.0% | Added |
| UBS Group AG | 2,882 | $5.00K | 0.00% | +2,882 | New |
| Steward Partners Investment Advisory, LLC | 1,666 | $3.00K | 0.00% | 00.0% | Unchanged |
| TAP Consulting, LLC | 500 | $1.00K | 0.00% | +500 | New |
| Bank of Montreal | 0 | $0 | 0.00% | −38,053−100.0% | Sold out |
| Davenport & Co LLC | 0 | $0 | 0.00% | −27,750−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −22,900−100.0% | Sold out |
| Gerber Kawasaki Wealth & Investment Management | 0 | $0 | 0.00% | −1−100.0% | Sold out |